These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 24075062)

  • 21. Absence of expression of SMARCB1/INI1 in malignant rhabdoid tumors of the central nervous system, kidneys and soft tissue: an immunohistochemical study with implications for diagnosis.
    Sigauke E; Rakheja D; Maddox DL; Hladik CL; White CL; Timmons CF; Raisanen J
    Mod Pathol; 2006 May; 19(5):717-25. PubMed ID: 16528370
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Uterine neoplasms composed of rhabdoid cells do not exhibit loss of INI1 immunoreactivity and are not related to childhood malignant rhabdoid tumor.
    Al-Hussaini M; Hirschowitz L; McCluggage WG
    Int J Gynecol Pathol; 2008 Apr; 27(2):236-42. PubMed ID: 18317218
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SMARCB1-deficient Tumors of Childhood: A Practical Guide.
    Pawel BR
    Pediatr Dev Pathol; 2018; 21(1):6-28. PubMed ID: 29280680
    [TBL] [Abstract][Full Text] [Related]  

  • 24. hSNF5/INI1-deficient tumours and rhabdoid tumours are convergent but not fully overlapping entities.
    Bourdeaut F; Fréneaux P; Thuille B; Lellouch-Tubiana A; Nicolas A; Couturier J; Pierron G; Sainte-Rose C; Bergeron C; Bouvier R; Rialland X; Laurence V; Michon J; Sastre-Garau X; Delattre O
    J Pathol; 2007 Feb; 211(3):323-30. PubMed ID: 17152049
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Re: Infrequent SMARCB1/INI1 gene alteration in epithelioid sarcoma: a useful tool in distinguishing epithelioid sarcoma from malignant rhabdoid tumor: Direct evidence of mutational inactivation of SMARCB1/INI1 in epithelioid sarcoma.
    Flucke U; Slootweg PJ; Mentzel T; Pauwels P; Hulsebos TJ
    Hum Pathol; 2009 Sep; 40(9):1361-2; author reply 1362-4. PubMed ID: 19683621
    [No Abstract]   [Full Text] [Related]  

  • 26. [Molecular genetics and immunophenotype of INI1/SMARCB in epithelioid sarcoma].
    Li L; Xia Q; Rao Q; Liu B; Wu B; Shi S; Yu B; Zhang R; Lu Z; Zhou X
    Zhonghua Bing Li Xue Za Zhi; 2014 Jun; 43(6):389-93. PubMed ID: 25208989
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinicopathologic study of deciduoid mesothelioma using SMARCB1/INI1 immunohistochemistry and fluorescence in situ hybridization.
    Kawai T; Ogata S; Nakashima H; Urabe S; Murakami I; Hiroshima K
    Hum Pathol; 2019 Nov; 93():23-29. PubMed ID: 31445842
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunohistochemistry of INI1 expression: a new tool for old challenges in CNS and soft tissue pathology.
    Judkins AR
    Adv Anat Pathol; 2007 Sep; 14(5):335-9. PubMed ID: 17717433
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epigenetic regulation of SMARCB1 By miR-206, -381 and -671-5p is evident in a variety of SMARCB1 immunonegative soft tissue sarcomas, while miR-765 appears specific for epithelioid sarcoma. A miRNA study of 223 soft tissue sarcomas.
    Sápi Z; Papp G; Szendrői M; Pápai Z; Plótár V; Krausz T; Fletcher CD
    Genes Chromosomes Cancer; 2016 Oct; 55(10):786-802. PubMed ID: 27223121
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary epithelioid sarcoma of bone: report of a unique case, with immunohistochemical and fluorescent in situ hybridization confirmation of INI1 deletion.
    Raoux D; Péoc'h M; Pedeutour F; Vaunois B; Decouvelaere AV; Folpe AL
    Am J Surg Pathol; 2009 Jun; 33(6):954-8. PubMed ID: 19342946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Highly aggressive behavior of malignant rhabdoid tumor: a special reference to SMARCB1/INI1 gene alterations using molecular genetic analysis including quantitative real-time PCR.
    Kohashi K; Oda Y; Yamamoto H; Tamiya S; Izumi T; Ohta S; Taguchi T; Suita S; Tsuneyoshi M
    J Cancer Res Clin Oncol; 2007 Nov; 133(11):817-24. PubMed ID: 17486366
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Specificity and sensitivity of INI-1 labeling in epithelioid sarcoma. Loss of INI1 expression as a frequent immunohistochemical event in synovial sarcoma.
    Mularz K; Harazin-Lechowska A; Ambicka A; Kruczak A; Rozmus-Piętoń M; Marchińska-Osika U; Swiątkiewicz I; Król M; Pabis D; Januś G; Ryś J
    Pol J Pathol; 2012 Nov; 63(3):179-83. PubMed ID: 23161234
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Claudin-4 expression distinguishes SWI/SNF complex-deficient undifferentiated carcinomas from sarcomas.
    Schaefer IM; Agaimy A; Fletcher CD; Hornick JL
    Mod Pathol; 2017 Apr; 30(4):539-548. PubMed ID: 28084340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SMARCB1/INI1 tumor suppressor gene is frequently inactivated in epithelioid sarcomas.
    Modena P; Lualdi E; Facchinetti F; Galli L; Teixeira MR; Pilotti S; Sozzi G
    Cancer Res; 2005 May; 65(10):4012-9. PubMed ID: 15899790
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pattern of SMARCB1 (INI1) and SMARCA4 (BRG1) in poorly differentiated endometrioid adenocarcinoma of the uterus: analysis of a series with emphasis on a novel SMARCA4-deficient dedifferentiated rhabdoid variant.
    Strehl JD; Wachter DL; Fiedler J; Heimerl E; Beckmann MW; Hartmann A; Agaimy A
    Ann Diagn Pathol; 2015 Aug; 19(4):198-202. PubMed ID: 25920939
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The diagnostic utility of reduced immunohistochemical expression of SMARCB1 in synovial sarcomas: a validation study.
    Ito J; Asano N; Kawai A; Yoshida A
    Hum Pathol; 2016 Jan; 47(1):32-7. PubMed ID: 26520417
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathology and diagnosis of SMARCB1-deficient tumors.
    Margol AS; Judkins AR
    Cancer Genet; 2014 Sep; 207(9):358-64. PubMed ID: 25246033
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SWI/SNF Chromatin-remodeling Complex Status in SMARCB1/INI1-preserved Epithelioid Sarcoma.
    Kohashi K; Yamamoto H; Yamada Y; Kinoshita I; Taguchi T; Iwamoto Y; Oda Y
    Am J Surg Pathol; 2018 Mar; 42(3):312-318. PubMed ID: 29309303
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renal medullary carcinoma: rhabdoid features and the absence of INI1 expression as markers of aggressive behavior.
    Cheng JX; Tretiakova M; Gong C; Mandal S; Krausz T; Taxy JB
    Mod Pathol; 2008 Jun; 21(6):647-52. PubMed ID: 18327209
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ewing Sarcoma and Atypical Teratoid Rhabdoid Tumor: A FISH and Immunohistochemical Comparison.
    Pacheco MC; Dolan M; Bendel A
    Pediatr Dev Pathol; 2017; 20(5):381-386. PubMed ID: 28382842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.